Gastrointestinal Cancer

Gastrointestinal Cancer

32 items identified
A022104 (JANUS): Locally Advanced Rectal Cancer
ABBV-400 for Advanced Solid Tumors
AMG 510 in Advanced Solid Tumors With KRAS p.G12C Mutation
ARC-21 (Gastrointestinal Cancer)
Chemotherapy With or Without 9-ING-41 for Pancreatic Cancer (Actuate 1801)
Circulating Biomarkers for Immunotherapy Resistance in Liver Cancer
COMPOSE Study (Neuroendocrine Tumors)
Coping Together-2 (Cancer Support)
CRSP-ONC-005 (Solid Tumors)
DKN-01 in Combination with Tislelizumab ± Chemotherapy in Patients with Gastric Cancer
Domvanalimab and zimberelimab versus nivolumab in gastroesophageal cancer (STAR-221)
Duke Gastric and Gastroesophageal Junction Cancer Patient Registry
EAY191 (ComboMATCH)
FEATURES OF PRIMARY AND ADAPTIVE IMMUNOTHERAPY RESISTANCE IN MICROSATELLITE INSTABLE CANCERS
GRECO-2: GC4711 + SBRT for pancreatic cancer
Lyell LYL845 (Solid Tumors)
MEM-288 (solid tumors)
MOUNTAINEER-03 (Colorectal Cancer)
Multi-Kinase Inhibitor with or without Atezolizumab in Previously Treated Liver Cancer
NIT-110 (Solid tumors)
NRG-GI005 Stage IIA Colon Cancer
NRG-GI008 Colon Cancer
OncoCHAT (Advanced Solid Cancer)
Pembrolizumab plus lenvatinib and belzutifan for specified solid tumors
Phase 2 Chemo with or without Hepatic Artery Infusion for IHCC (Cholangiocarcinoma)
Precision Medicine mCRC (Liver Cancer)
PT-112 in mCRPC (Prostate Cancer)
Stool collection study for cancer patients treated with irinotecan-based therapy
Synthekine STK-012 (Solid Tumors)
TCR2-18-01_gavo-cel (Mesothelin-Expressing Cancers)
The 3PC Trial (Intraductal Papillary Mucinous Neoplasm)
The Safety and Efficacy of Targeted Therapies in Metastatic Colorectal Cancer (Intrinsic)